Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2002
09/12/2002US20020128268 Cosmetic and dermatological preparations; use in nutrition or consumption
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020127502 Cyanine dye
09/12/2002CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
09/11/2002EP1237882A1 Thiazolidines and use thereof for corrosion inhibition
09/11/2002EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP0912504B1 Oxazolidine ester
09/11/2002EP0731788B1 Prolyl endopeptidase inhibitors
09/11/2002CN1368966A Process for preparation of thiazole derivatives
09/11/2002CN1368961A Compounds for modulation of PPAP gamma activity
09/11/2002CN1368956A Carbamate derivatives and agricultural/horticultural bactericides
09/11/2002CN1090620C New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them
09/10/2002US6448408 Process for the preparation of heteroaryl-phenylalanines
09/10/2002US6448401 Reacting a triazole antifungal compound containing a secondary or tertiary hydroxyl group with a protected monochloromethyl phosphate; iodide ion source; organic solvent; base
09/10/2002US6448399 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-n-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide.
09/10/2002US6448396 Compounds useful as neuro-protective agents
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
09/10/2002US6448272 Myt1 kinase inhibitors
09/10/2002US6448228 Functionalized oligopeptide having high fungicidal activity; one or two aliphatic amino acids such as valine, leucine and isoleucine, conjugated to one or two aromatic amino acids, such as phenyl-glycine, phenylalanine and beta-phenylalanine
09/10/2002US6448201 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation, and their use as herbicides and plant growth regulators
09/06/2002WO2002068586A2 Hiv/fiv protease inhibitors
09/06/2002WO2002068380A1 Synthetic excitatory amino acids
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/06/2002WO2002050024A3 Thiazolidinediones
09/06/2002WO2002043648A8 Compounds active at the glucocorticoid receptor ii
09/06/2002WO2002036580A3 Benzoxazole lpaat- beta inhibitors and uses thereof
09/06/2002WO2002012250A3 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
09/05/2002US20020123631 Reacting an aromatic or heteroaromatic carbamate with a heteroarylamine compound to form an intermediate, coupling the intermediate with an electrophile in suitable base and a catalyst
09/05/2002US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol
09/05/2002US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease
09/05/2002US20020123512 Pharmaceutical composition
09/05/2002US20020123502 5-(4-(2-(2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl) -ethoxy)phenyl methyl)thiazolidine-2,4-dione for example; also oxazolidine-2,4-dione, and 1,2,4-oxadiazolidine-3,5-dione derivatives; reducing blood glucose levels
09/05/2002US20020123484 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
09/05/2002US20020123483 IL-8 receptor ligands - drugs for inflammatory and autoimmune diseases
09/05/2002US20020122979 Fluoroalkylphosphate salts, and process for the preparation of these substances
09/05/2002DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus
09/04/2002EP1236732A1 Fluoroalkylphosphate salts and preparation thereof
09/04/2002EP1236712A1 Amidinophenylpyruvic acid derivative
09/04/2002EP1235816A1 Benzoylcyclohexandione and benzoylpyrazols, method for the production and use thereof as herbicides and plant growth regulators
09/04/2002EP1235805A2 Immunoassay for neonicotinyl insecticides
09/04/2002EP1080086B1 Dihydropyrimidines
09/04/2002EP0700397B1 New thiazolidindiones and drugs containing them
09/04/2002CN1367785A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group
09/04/2002CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds
09/04/2002CN1090019C 组合物 The composition
09/03/2002US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/2002US6444669 8,8a-dihydroindeno[1,2-d]thiazole derivatives which carry in the 2-position a substituent having a sulfonamide structure or sulfone structure; processes for their preparation and their use as medicaments
09/03/2002CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors
08/2002
08/29/2002WO2002066442A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002066035A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/29/2002WO2002066034A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
08/29/2002WO2002042273A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO2002002506A3 Compounds to treat alzheimer's disease
08/29/2002WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists
08/29/2002WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120151 Composition and device for detecting leukocytes in urine
08/29/2002US20020120150 Process for the preparation of thiazolidinedione derivatives
08/29/2002US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/29/2002US20020120007 Benzamide inhibitors of factor Xa
08/29/2002US20020119995 Inverse thiazolylamide derivatives
08/29/2002US20020119994 LFA-1 Antagonist compounds
08/29/2002CA2435446A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
08/29/2002CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002EP1233967A1 Pyridinones to treat and prevent bacterial infections
08/28/2002EP1233952A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
08/28/2002EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
08/28/2002EP0918759B1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same
08/28/2002EP0873323B1 Substituted thiazolines and their use for controlling animal pests
08/28/2002EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
08/28/2002EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease
08/28/2002CN1366524A Sulfonamide derivative as matrix metalloproteinase inhibitor
08/28/2002CN1366523A Process for preparing amic acid esters
08/28/2002CN1366522A Process for producing substituted alkylamine derivative
08/28/2002CN1366521A Substituted 1-aza-2-imino heterocycles and their use as nicotinic acetylcholine receptors activators
08/28/2002CN1365975A Condensation reagent and its preparation method
08/27/2002US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt
08/27/2002US6441185 Method for producing thiazolidinediones, and new thiazolidinediones
08/27/2002US6441184 Such as n-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type ii diabetes
08/27/2002US6441180 Tetrazolyl-phenyl actamide glucokinase activators
08/27/2002US6441043 Glyoxylic acid amides
08/27/2002US6441042 Hydroxamic acid derivatives as antibacterials
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002US6441021 Type-iv collagenase inhibitors
08/27/2002US6441012 Chemical compounds
08/27/2002US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
08/27/2002US6440749 Administering a thiazole compound
08/27/2002CA2224738C Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
08/24/2002CA2372751A1 Fluoralkylphosphate salts, and process for the preparation of these substances
08/22/2002WO2002064577A2 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione
08/22/2002WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064554A1 Cyanothioacetamide derivative and process for producing the same
08/22/2002WO2002064550A1 Glucocorticoid receptor modulators